The timing could not be more significant. According to the National Mental Health Survey 2015–16, conducted by NIMHANS across ...
Leiutis Pharma gets CDSCO nod for global-first synthetic CBD therapy for mild to moderate anxiety disorders: Our Bureau, Bengaluru Tuesday, July 14, 2026, 16:25 Hrs [IST] Leiutis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results